iShares iBonds Dec 2025 Term Corp ETF (IBDQ)

25.10 +0.20  +0.80% NYSE Arca Apr 7, 20:00 Delayed 2m USD
View Full Chart
Price Chart

Key Stats

Net Asset Value 24.92
Discount or Premium to NAV 0.72%
Turnover Ratio 6.00%
1 Year Fund Level Flows 205.58M
View All IBDQ News

News

Performance & Returns

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -5.56% -6.28% -3.80% 75
3M -2.68% -3.19% -2.88% 65
6M -1.96% -2.43% -2.39% 60
YTD -2.52% -3.00% -2.66% 65
1Y 4.70% 4.20% 3.26% 25
3Y 4.06% 3.93% 2.91% 14
5Y 3.18% 3.18% 2.66% 1
10Y -- -- -- --
15Y -- -- -- --
20Y -- -- -- --
As of April 7, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 0.12% 0.12% 0.00%
Stock 0.00% 0.00% 0.00%
Bond 97.08% 97.08% 0.00%
Convertible 2.80% 2.80% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of April 6, 2020

Region Exposure

Americas 88.04%
North America 87.26%
Latin America 0.78%
Greater Europe 9.50%
United Kingdom 4.92%
Europe Developed 4.58%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 2.46%
Japan 1.38%
Australasia 0.58%
Asia Developed 0.40%
Asia Emerging 0.10%
Market Classification
% Developed Markets 98.72%
% Emerging Markets 1.28%
As of April 6, 2020. Region breakdown data is calculated by using the long position holdings of the portfolio.

IBDQ Bond Exposure

Government 0.00%
Corporate 99.78%
Securitized 0.10%
Municipal 0.00%
Cash 0.12%
Derivative 0.00%
As of April 6, 2020

IBDQ Bond Credit Quality Exposure

AAA 2.22%
AA 7.21%
A 32.12%
BBB 58.44%
BB 0.00%
B 0.00%
Below B 0.00%
Not Rated 0.00%
As of Dec. 31, 2019

IBDQ Bond Maturity Exposure

1 to 7 Days 0.00%
8 to 30 Days 0.00%
31 to 90 Days 0.00%
91 to 182 Days 0.00%
183 to 364 Days 0.00%
1 to 3 Years 0.00%
3 to 5 Years 37.38%
5 to 7 Years 62.59%
7 to 10 Years 0.03%
10 to 15 Years 0.00%
15 to 20 Years 0.00%
20 to 30 Years 0.00%
Over 30 Years 0.00%
As of April 6, 2020
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
-- CVS Health Corp 4.1% 1.35% -- --
-- Charter Communications Operating, LLC/Charter Communications Operating Capi 1.28% -- --
-- AT&T Inc 3.4% 1.26% -- --
-- Visa Inc 3.15% 1.24% -- --
-- AbbVie Inc. 3.6% 1.00% -- --
-- Microsoft Corporation 3.13% 0.88% -- --
-- Morgan Stanley 4% 0.84% -- --
-- Shell International Finance B.V. 3.25% 0.83% -- --
-- Allergan Funding SCS 3.8% 0.82% -- --
-- CVS Health Corp 3.88% 0.81% -- --
As of April 6, 2020
Advertisement

Basic Info

Investment Strategy
The investment seeks to track the investment results of the Bloomberg Barclays December 2025 Maturity Corporate Index which composed of U.S. dollar-denominated, investment-grade corporate bonds maturing in 2025. The fund generally will invest at least 90% of its assets in the component securities of the underlying index. The underlying index is composed of U.S. dollar-denominated, taxable, investment-grade corporate bonds scheduled to mature after December 31, 2024 and before December 16, 2025.
General
Security Type Exchange-Traded Fund
Equity Style --
Fixed Income Style Medium Quality/Moderate Sensitivity
Broad Asset Class Taxable Bond
Broad Category Fixed Income
Category Name Target Maturity
Prospectus Objective Corporate Bond - General
Fund Owner Firm Name iShares
Benchmark Index
BBgBarc Dec 2025 Maturity Corp TR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
James Mauro 4.98 yrs
Scott Radell 4.98 yrs

Net Fund Flows

1M -41.29M
3M 76.10M
6M 112.27M
YTD 76.10M
1Y 205.58M
3Y 426.34M
5Y 572.98M
10Y --
As of March 31, 2020

Risk Info

Beta (5Y) --
Max Drawdown (All) 15.19%
Historical Sharpe Ratio (10Y) --
Historical Sortino (All) 0.2817
30-Day Rolling Volatility 23.98%
Daily Value at Risk (VaR) 1% (All) 0.97%
Monthly Value at Risk (VaR) 1% (All) 4.78%

Fundamentals

Dividend Yield TTM (4-7-20) 3.22%
30-Day SEC Yield (3-25-20) 2.74%
7-Day SEC Yield --
Current Yield 3.62%
Yield to Maturity 2.48%
Effective Duration 4.754
Average Coupon 3.71%
Average Credit Score 9.00 (BBB)
Average Price 103.45
Number of Holdings 410
As of April 6, 2020

Comparables

Edit

Attributes

Key Dates
Inception Date 3/11/2015
Termination Date
Last Annual Report Date 10/31/2019
Last Prospectus Date 2/28/2020
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.